Pulmonx Corp — Director's Dealing 2023

Mar 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2023-03-01

Reporting Person: Rose Geoffrey Beran (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-01	Common Stock	S	437	$11.03	Disposed	181762	Direct
2023-03-01	Common Stock	S	769	$11.03	Disposed	180993	Direct
2023-03-01	Common Stock	A	78900	$0.00	Acquired	259893	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-01	Employee Stock Option (right to buy)	$11.48	A	54000	Acquired	2033-02-28	Common Stock (54000)	Direct

Footnotes

F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

F2: Includes 1,162 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on February 15, 2023.

F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022.

F4: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2023.

F5: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2023.